Liao et al. reported that PPIA knockdown significantly inhibited invasion and migration in oral squamous cell carcinoma (OSCC) cells, while recombinant PPIA enhanced proliferation and activated the ERK1/2 and p38MAPK pathways through CD147 (BSG) [67]. Here, MAPK3 is linked to oral cavity squamous cell carcinoma.